Find recruiting clinical trials for blood cancers and disorders in the UK � non-Hodgkin lymphoma (NHL), Hodgkin lymphoma, leukaemias (AML, ALL, CLL), MDS, myeloma, and more. See treatment pathways and where trials fit in.
Free to use � Live data from ClinicalTrials.gov � Updated hourly
Answer a few questions about your condition and we'll match you to the most relevant clinical trials.
The most common haematological malignancy. Includes DLBCL, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, and T-cell lymphomas.
Highly curable lymphoma, especially in early stages. Relapsed/refractory patients may benefit from novel therapies including checkpoint inhibitors and CAR-T.
Aggressive blood cancer requiring urgent treatment. Rapidly evolving treatment landscape with targeted therapies (FLT3, IDH inhibitors) and novel combinations.
Most common adult leukaemia. Treatment revolutionised by BTK inhibitors (ibrutinib, acalabrutinib) and BCL-2 inhibitor (venetoclax).
Plasma cell cancer with multiple treatment lines. BCMA-targeted therapies (CAR-T, bispecifics) represent the biggest advance in decades.
Myelodysplastic syndromes and myeloproliferative neoplasms. Range from low-risk (observation) to high-risk (approaching AML). Growing trial landscape.
Loading trials from ClinicalTrials.gov...
Haematology trials cover blood disorders including anaemia, thrombocytopenia, clotting disorders, myeloproliferative neoplasms, and rare blood diseases. Search for your specific condition to find relevant trials.
Yes. Many rare blood disorders (paroxysmal nocturnal haemoglobinuria, aplastic anaemia, TTP, cold agglutinin disease) have active clinical trials. Orphan drug development has increased options for rare conditions.
Use our search above to find trials that match your condition and location. Review the eligibility criteria carefully.
Talk to your GP or specialist about any trials you are interested in. They can help determine if a trial is appropriate for you.
Reach out to the trial team directly using the contact information on the ClinicalTrials.gov listing. They will guide you through screening.
If you meet the criteria and decide to participate, you will go through informed consent and begin the trial process.